A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
A Silicon Valley startup backed by OpenAI’s Sam Altman and Coinbase’s Brian Armstrong is pursuing research that some fear ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Gene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has been challenging. In the latest case, the scientists developed a CRISPR ...
Genetically engineered humans may still sound like the stuff of science fiction, but the quest to create genetically modified babies is getting a reboot. NPR's health correspondent Rob Stein brings us ...
Two prominent leaders in the scientific community have publicly denounced plans recently announced by Russian molecular biologist Denis Rebrikov, PhD, to use CRISPR technology to edit the DNA of human ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback